Myocardial Infarction

Myocardial infarction (MI), commonly called a heart attack, is the leading cause of ICU admissions and death across the globe. It occurs due to the sudden reduction or stoppage of blood flow to the myocardium due to narrowing or obstruction of coronary arteries. This results in myocardial injury due to abrupt myocardial oxygen deprivation. Therefore, MI is a fatal condition requiring emergency medical intervention to restore blood flow and prevent complications like heart failure, cardiogenic shock, cardiac arrhythmia, and cardiac arrest. Explore advanced search options by clicking CLINICAL DIAGNOSIS, ICD-10-CM CODES, and LABORATORY PARAMETERS.

Show rows
|< < of > >|

Clinical presentations of MI:

Mild ischaemic episodes are often asymptomatic and unnoticed. Clinical presentation of myocardial ischaemia includes chest pain radiating to the left arm, a sensation of tightness, pressure, and squeezing chest pain accompanied by shortness of breath, sweating, nausea, and vomiting. Besides, the patient will also experience extreme weakness, tachycardia or bradycardia, dizziness, followed by sometimes fainting.


Insight to the MI Samples We Offer:

Central BioHub is a trusted global biospecimen supplier, offering a cutting-edge solution to worldwide biosample procuring and management systems. We offer thousands of human biospecimen derived from consented patients of all age groups. We provide you curated collection of human human serum and plasma samples conscientiously tested for cardiovascular disease biological markers. Blood samples are tested for troponin I (TnI), troponin T (TnT), brain natriuretic peptide (BNP), N-terminal prohormone b-type natriuretic peptide (NT-proBNP), myoglobin, creatine kinase-MB (CK-MB), and D-dimer to confirm the myocardial infarction.

Every sample we offer is handled with the utmost care and readily available for purchase. For optimizing maximum research output, our samples are well annotated with relevant clinical information and patient demographics like age, gender, ethnicity, and country of sample origin. To meet your research endpoints, our supplier's stores every human biosample at <-18°C to preserve its physiological properties. Furthermore, Our online marketplace addresses prompt demand and supply, which keeps the system running with complete efficacy. With numerous research institutions recognizing the platform as reliable, Central BioHub is creating a breakthrough in the regime of bioresearch. For more information on research samples, reach out to us today. We are curious to hear from you.

Myocardial infarction (MI), commonly known as a heart attack, is the most prevalent cause of ICU admissions and mortality worldwide. It occurs when the blood flow to the myocardium is suddenly reduced or stopped due to constriction or occlusion of coronary arteries. As a result of acute myocardial oxygen deprivation, myocardial damage occurs. As an outcome, MI is a life-threatening illness that needs immediate medical attention to restore blood flow and avoid consequences such as heart failure, cardiogenic shock, cardiac arrhythmia, and cardiac arrest.
High blood cholesterol and high blood pressure, obesity, smoking, diabetes, lack of exercise, poor nutrition, and excessive alcohol use are risk factors for a heart attack.
Myocardial infarction (MI) is commonly known as heart attack. It is an emergency condition requiring immediate medical care. Common symptoms of MI are sudden chest pain radiating to the jaws and left shoulder, shortness of breath, nausea, heartburn, cold sweat, fatigue, and loss of consciousness.
Central BioHub, the leading human biospecimen marketplace, offers high-quality human serum and plasma samples for cardiovascular research. Our samples originate from consented and diagnosed donors and are stored at = -18°C in our biobank.